From Frequency Nabs $32M, Will Push Hearing-Loss Drugs To Human Studies:

Cochlear hair cells
Cochlear hair cells—

Cochlear hair cells, photo courtesy of Will McLean, VP Biology and Regenerative Medicine at Frequency Therapeutics.

Xconomy on Demand

We offer a number of ways to subscribe for free!

Subscribe Now

© 2007-2020, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.